Filed 21d ago· May 13, 2026
41 days to disclose
Byron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
SP Eli Lilly and Company
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 118
Filed 21d ago· May 13, 2026
41 days to discloseByron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
Filed 26d ago· May 8, 2026
24 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+14.6% vs S&P 500
Trade dateApr 14, 2026
Filed 1mo ago· May 1, 2026
23 days to disclose
Lizzie Fletcher
DHouseTexas-07
↓sold
Eli Lilly
LLY
$1K-$15K
−0.8% vs S&P 500
Trade dateApr 8, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Eli Lilly
LLY
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 2mo ago· Mar 24, 2026
39 days to disclose
Angus S., Jr. King
ISenateMaine
↓sold
Eli Lilly
LLY
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 13, 2026
Filed 2mo ago· Mar 6, 2026
8 days to disclose
David J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+8.9% vs S&P 500
Trade dateFeb 26, 2026
Filed 3mo ago· Feb 20, 2026
11 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−5.0% vs S&P 500
Trade dateFeb 9, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−4.6% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Jan 26, 2026
28 days to discloseAngus S., Jr. King
ISenateMaine
↑bought
Eli Lilly
LLY
$1K-$15K
+3.8% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 16, 2026
18 days to disclose
Markwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
+2.5% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 5mo ago· Dec 19, 2025
9 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−2.4% vs S&P 500
Trade dateDec 10, 2025
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+5.1% vs S&P 500
Trade dateNov 18, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 8, 2025
17 days to disclose
John Boozman
RSenateArkansas
↓sold
Eli Lilly
LLY
$1K-$15K
−3.9% vs S&P 500
Trade dateNov 21, 2025
Filed 7mo ago· Nov 4, 2025
11 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↑bought
Eli Lilly
LLY
$1K-$15K
+26.2% vs S&P 500
Trade dateOct 24, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+40.8% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+52.2% vs S&P 500
Trade dateAug 11, 2025
Filed 8mo ago· Sep 12, 2025
129 days to disclose · 84 past 45-day windowVal T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+10.6% vs S&P 500
Trade dateMay 6, 2025
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Eli Lilly
LLY
$1K-$15K
+32.3% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$15K-$50K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Aug 25, 2025
96 days to disclose · 51 past 45-day window
Jonathan L. Jackson
DHouseIllinois-01
↓sold
Eli Lilly
LLY
$1K-$15K
+12.9% vs S&P 500
Trade dateMay 21, 2025
Filed 9mo ago· Aug 25, 2025
124 days to disclose · 79 past 45-day windowJonathan L. Jackson
DHouseIllinois-01
↑bought
Eli Lilly
LLY
$1K-$15K
+17.8% vs S&P 500
Trade dateApr 23, 2025
Filed 9mo ago· Aug 13, 2025
28 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
Eli Lilly
LLY
$1K-$15K
+10.6% vs S&P 500
Trade dateJul 16, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
34 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Eli Lilly
LLY
$1K-$15K
+24.6% vs S&P 500
Trade dateJul 10, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
65 days to disclose · 20 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Eli Lilly
LLY
$1K-$15K
+10.7% vs S&P 500
Trade dateJun 9, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
245 days to disclose · 200 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Eli Lilly
LLY
$1K-$15K
+28.1% vs S&P 500
Trade dateDec 11, 2024
⚑ Pharmaceutical
Filed 9mo ago· Aug 12, 2025
244 days to disclose · 199 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$50K-$100K
+28.1% vs S&P 500
Trade dateDec 11, 2024
Filed 10mo ago· Jul 14, 2025
41 days to discloseJonathan L. Jackson
DHouseIllinois-01
↓sold
Eli Lilly
LLY
$15K-$50K
+11.6% vs S&P 500
Trade dateJun 3, 2025
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Eli Lilly
LLY
$100K-$250K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 11, 2025
29 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+12.6% vs S&P 500
Trade dateMay 13, 2025
Filed 11mo ago· Jun 11, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+24.2% vs S&P 500
Trade dateMay 1, 2025
Filed 12mo ago· Jun 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Eli Lilly
LLY
$1K-$15K
+12.0% vs S&P 500
Trade dateMay 30, 2025
Filed 1.0y ago· May 19, 2025
5 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+34.2% vs S&P 500
Trade dateMay 14, 2025
Filed 1.0y ago· May 16, 2025
35 days to disclose
Dan Newhouse
RHouseWashington-04
↓sold
Eli Lilly
LLY
$1K-$15K
+8.5% vs S&P 500
Trade dateApr 11, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+7.0% vs S&P 500
Trade dateApr 9, 2025
Filed 1.1y ago· May 14, 2025
37 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
+10.4% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 13, 2025
22 days to discloseJonathan L. Jackson
DHouseIllinois-01
↑bought
Eli Lilly
LLY
$15K-$50K
+17.0% vs S&P 500
Trade dateApr 21, 2025
Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
Eli Lilly
LLY
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+22.7% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· Apr 28, 2025
20 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
Eli Lilly
LLY
$1K-$15K
+14.2% vs S&P 500
Trade dateMar 3, 2025
Filed 1.1y ago· Apr 10, 2025
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+0.6% vs S&P 500
Trade dateMar 10, 2025
Filed 1.2y ago· Mar 6, 2025
15 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+1.4% vs S&P 500
Trade dateFeb 19, 2025
Filed 1.3y ago· Feb 21, 2025
11 days to disclose
Ron Wyden
DSenateOregon
↓sold
Eli Lilly
LLY
$50K-$100K
+1.5% vs S&P 500
Trade dateFeb 10, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 21, 2025
30 days to discloseRon Wyden
DSenateOregon
↑bought
Eli Lilly
LLY
$50K-$100K
+37.4% vs S&P 500
Trade dateJan 22, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 10, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.8% vs S&P 500
Trade dateJan 8, 2025
Filed 1.3y ago· Jan 27, 2025
6 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+39.9% vs S&P 500
Trade dateJan 21, 2025
Filed 1.4y ago· Jan 14, 2025
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+8.1% vs S&P 500
Trade dateDec 18, 2024
Filed 1.4y ago· Jan 14, 2025
29 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+6.6% vs S&P 500
Trade dateDec 16, 2024
Filed 1.4y ago· Jan 14, 2025
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.3% vs S&P 500
Trade dateDec 13, 2024
Filed 1.4y ago· Jan 14, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.3% vs S&P 500
Trade dateDec 12, 2024
Filed 1.4y ago· Jan 14, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+4.5% vs S&P 500
Trade dateDec 11, 2024
Filed 1.4y ago· Jan 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+3.1% vs S&P 500
Trade dateDec 10, 2024
Filed 1.4y ago· Jan 14, 2025
36 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.6% vs S&P 500
Trade dateDec 9, 2024
Filed 1.4y ago· Dec 27, 2024
3 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+27.8% vs S&P 500
Trade dateDec 24, 2024
Filed 1.5y ago· Dec 12, 2024
34 days to disclose
Greg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$15K-$50K
−1.1% vs S&P 500
Trade dateNov 8, 2024
⚑ Pharmaceutical
Filed 1.5y ago· Dec 5, 2024
16 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.2% vs S&P 500
Trade dateNov 19, 2024
Filed 1.5y ago· Dec 5, 2024
21 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.8% vs S&P 500
Trade dateNov 14, 2024
Filed 1.6y ago· Nov 7, 2024
8 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
+33.9% vs S&P 500
Trade dateOct 30, 2024
⚑ Pharmaceutical
Filed 1.6y ago· Nov 6, 2024
21 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
−3.1% vs S&P 500
Trade dateOct 16, 2024
Filed 1.8y ago· Aug 21, 2024
237 days to disclose · 192 past 45-day window
Jared Moskowitz
DHouseFlorida-23
↑bought
Eli Lilly
LLY
$1K-$15K
+72.7% vs S&P 500
Trade dateDec 28, 2023
Filed 1.8y ago· Aug 21, 2024
355 days to disclose · 310 past 45-day windowJared Moskowitz
DHouseFlorida-23
↑bought
Eli Lilly
LLY
$1K-$15K
+78.3% vs S&P 500
Trade dateSep 1, 2023
Filed 1.8y ago· Aug 15, 2024
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.5% vs S&P 500
Trade dateJul 1, 2024
Filed 1.8y ago· Aug 14, 2024
72 days to disclose · 27 past 45-day windowGreg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$1K-$15K
+28.9% vs S&P 500
Trade dateJun 3, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
461 days to disclose · 416 past 45-day windowGreg Landsman
DHouseOhio-01
↑bought
Eli Lilly
LLY
$1K-$15K
+130.1% vs S&P 500
Trade dateMay 11, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
559 days to disclose · 514 past 45-day windowGreg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$1K-$15K
+11.6% vs S&P 500
Trade dateFeb 2, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
574 days to disclose · 529 past 45-day windowGreg Landsman
DHouseOhio-01
↑bought
Eli Lilly
LLY
$1K-$15K
+188.1% vs S&P 500
Trade dateJan 18, 2023
⚑ Pharmaceutical
Filed 2.0y ago· Jun 12, 2024
713 days to disclose · 668 past 45-day window
Roger Williams
RHouseTexas-25
↑bought
Eli Lilly
LLY
$1K-$15K
+83.4% vs S&P 500
Trade dateJun 30, 2022
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+23.5% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· Apr 25, 2024
15 days to discloseDan Newhouse
RHouseWashington-04
↓sold
Eli Lilly
LLY
$1K-$15K
+22.9% vs S&P 500
Trade dateApr 10, 2024
⚑ Pharmaceutical
Filed 2.2y ago· Mar 7, 2024
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+3.0% vs S&P 500
Trade dateFeb 8, 2024
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.2% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 22, 2024
25 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Eli Lilly
LLY
$1K-$15K
+9.0% vs S&P 500
Trade dateDec 28, 2023
Filed 2.4y ago· Jan 18, 2024
35 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$1K-$15K
+2.8% vs S&P 500
Trade dateDec 14, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Dec 8, 2023
22 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+63.7% vs S&P 500
Trade dateNov 16, 2023
Filed 2.5y ago· Dec 8, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+16.9% vs S&P 500
Trade dateNov 13, 2023
Filed 2.6y ago· Nov 11, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+57.9% vs S&P 500
Trade dateOct 16, 2023
Filed 2.6y ago· Nov 1, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$1K-$15K
−1.0% vs S&P 500
Trade dateOct 3, 2023
Filed 2.6y ago· Oct 17, 2023
27 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
−7.6% vs S&P 500
Trade dateSep 20, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 15, 2023
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+64.3% vs S&P 500
Trade dateSep 12, 2023
Filed 2.6y ago· Oct 13, 2023
35 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 12, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
−12.3% vs S&P 500
Trade dateSep 13, 2023
Filed 2.7y ago· Oct 4, 2023
21 days to disclose
John R. Curtis
RSenateUtah
↑bought
Eli Lilly
LLY
$1K-$15K
−12.3% vs S&P 500
Trade dateSep 13, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 16, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+11.5% vs S&P 500
Trade dateAug 22, 2023
Filed 3.0y ago· Jun 11, 2023
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+134.2% vs S&P 500
Trade dateMay 9, 2023
Filed 3.0y ago· Jun 11, 2023
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+11.4% vs S&P 500
Trade dateMay 8, 2023
Filed 3.0y ago· Jun 11, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+135.5% vs S&P 500
Trade dateMay 5, 2023
Filed 3.0y ago· May 26, 2023
30 days to discloseDan Newhouse
RHouseWashington-04
↑bought
Eli Lilly
LLY
$1K-$15K
+136.9% vs S&P 500
Trade dateApr 26, 2023
⚑ Pharmaceutical
Filed 3.0y ago· May 26, 2023
294 days to disclose · 249 past 45-day windowDan Newhouse
RHouseWashington-04
↓sold
Eli Lilly
LLY
$1K-$15K
+13.0% vs S&P 500
Trade dateAug 5, 2022
⚑ Pharmaceutical
Filed 3.1y ago· Apr 20, 2023
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$15K-$30K
+16.5% vs S&P 500
Trade dateMar 16, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to disclose
Daniel S. Goldman
DHouseNew York-10
↑bought
Eli Lilly
LLY
$1K-$15K
+215.9% vs S&P 500
Trade dateMar 6, 2023
Filed 3.2y ago· Mar 20, 2023
45 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Eli Lilly
LLY
$1K-$15K
+11.9% vs S&P 500
Trade dateFeb 3, 2023
Filed 3.2y ago· Mar 17, 2023
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+16.8% vs S&P 500
Trade dateFeb 28, 2023
Filed 3.2y ago· Mar 17, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+12.5% vs S&P 500
Trade dateFeb 17, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY SP Eli Lilly and Company | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Apr 14, 2026 24 days to disclose | Good buy·+$1.2K+14.4% +14.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 1, 2026 1mo ago | Lizzie Fletcher DHouseTexas-07 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Apr 8, 2026 23 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 24, 2026 2mo ago | Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Feb 26, 2026 8 days to disclose | Good buy·+$262+3.3% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 20, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Feb 9, 2026 11 days to disclose | Flat·+0.0% −5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Jan 16, 2026 17 days to disclose | Flat·+0.0% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Dec 10, 2025 9 days to disclose | Flat·+0.0% −2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Nov 18, 2025 27 days to disclose | Good buy·+$197+2.5% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2025 5mo ago | John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2025 7mo ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 24, 2025 11 days to disclose | Good buy·+$2.2K+27.9% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Eli Lilly LLY | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$2.6K+32.4% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$17.6K+54.2% +43.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$4.3K+54.2% +43.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 25, 2025 9mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | May 21, 2025 96 days to disclose · 51 past 45-day window | Flat·+0.0% +12.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 25, 2025 9mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 23, 2025 124 days to disclose · 79 past 45-day window | Good buy·+$2.2K+27.3% +17.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 16, 2025 28 days to disclose | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 10, 2025 34 days to disclose | Good buy·+$2.7K+33.5% +24.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 9, 2025 65 days to disclose · 20 past 45-day window | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Good buy·+$2.6K+32.6% +28.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 11, 2024 244 days to disclose · 199 past 45-day window | Good buy·+$24.4K+32.6% +28.1% vs S&P 500 | $50K-$100K midpoint $75K |
Jul 14, 2025 10mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | Jun 3, 2025 41 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Eli Lilly LLY | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $100K-$250K midpoint $175K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 13, 2025 29 days to disclose | Flat·+0.0% +12.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 1, 2025 41 days to disclose | Good buy·+$2.6K+32.9% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | May 30, 2025 7 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 14, 2025 5 days to disclose | Good buy·+$4K+49.5% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 16, 2025 1.0y ago | Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 11, 2025 35 days to disclose | Flat·+0.0% +8.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Apr 7, 2025 37 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2025 1.1y ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 21, 2025 22 days to disclose | Good buy·+$9.4K+29.0% +17.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | Eli Lilly LLY | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 5, 2025 1 day to disclose | Good buy·+$2.4K+30.2% +22.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | Eli Lilly LLY | Mar 3, 2025 44 days to disclose | Good buy·+$1.1K+13.5% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 10, 2025 31 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 19, 2025 15 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Feb 10, 2025 11 days to disclose | Flat·+0.0% +1.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Jan 22, 2025 30 days to disclose | Good buy·+$31.4K+41.9% +37.4% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jan 8, 2025 33 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Jan 21, 2025 6 days to disclose | Good buy·+$3.5K+44.1% +39.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 18, 2024 27 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 16, 2024 29 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 13, 2024 32 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 12, 2024 33 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 11, 2024 34 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 10, 2024 35 days to disclose | Flat·+0.0% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 9, 2024 36 days to disclose | Flat·+0.0% +2.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Dec 24, 2024 3 days to disclose | Good buy·+$2.8K+34.4% +27.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2024 1.5y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Nov 8, 2024 34 days to disclose | Flat·+0.0% −1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 19, 2024 16 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 14, 2024 21 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 7, 2024 1.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 30, 2024 8 days to disclose | Good buy·+$11.1K+34.1% +33.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 6, 2024 1.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Oct 16, 2024 21 days to disclose | Flat·+0.0% −3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Dec 28, 2023 237 days to disclose · 192 past 45-day window | Good buy·+$6.5K+81.7% +72.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Sep 1, 2023 355 days to disclose · 310 past 45-day window | Good buy·+$7.2K+89.5% +78.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jul 1, 2024 45 days to disclose | Flat·+0.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jun 3, 2024 72 days to disclose · 27 past 45-day window | Missed gain·−$507-6.3% +28.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | May 11, 2023 461 days to disclose · 416 past 45-day window | Good buy·+$11.4K+142.3% +130.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Feb 2, 2023 559 days to disclose · 514 past 45-day window | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jan 18, 2023 574 days to disclose · 529 past 45-day window | Good buy·+$16K+199.8% +188.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2024 2.0y ago | Roger Williams RHouseTexas-25 | ↑bought | Eli Lilly LLY | Jun 30, 2022 713 days to disclose · 668 past 45-day window | Good buy·+$13.8K+172.6% +83.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 25, 2024 2.1y ago | Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 10, 2024 15 days to disclose | Missed gain·−$1.3K-16.0% +22.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 8, 2024 28 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 22, 2024 2.4y ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Eli Lilly LLY | Dec 28, 2023 25 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 18, 2024 2.4y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 35 days to disclose | Good buy·+$4.3K+54.1% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Nov 16, 2023 22 days to disclose | Good buy·+$6.3K+79.3% +63.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 13, 2023 25 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 11, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Oct 16, 2023 26 days to disclose | Good buy·+$5.7K+71.2% +57.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Oct 3, 2023 29 days to disclose | Good buy·+$5.5K+68.3% −1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 17, 2023 2.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$17.9K+55.2% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Sep 12, 2023 33 days to disclose | Good buy·+$6.1K+76.1% +64.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Sep 13, 2023 29 days to disclose | Good buy·+$15.5K+47.6% −12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | John R. Curtis RSenateUtah | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.8K+47.6% −12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 16, 2023 2.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Aug 22, 2023 25 days to disclose | Flat·+0.0% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 9, 2023 33 days to disclose | Good buy·+$11.7K+146.4% +134.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 8, 2023 34 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 5, 2023 37 days to disclose | Good buy·+$11.7K+146.7% +135.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | Dan Newhouse RHouseWashington-04 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 26, 2023 30 days to disclose | Good buy·+$12K+149.7% +136.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Aug 5, 2022 294 days to disclose · 249 past 45-day window | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 16, 2023 35 days to disclose | Flat·+0.0% +16.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Eli Lilly LLY | Mar 6, 2023 42 days to disclose | Good buy·+$18.5K+230.9% +215.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Eli Lilly LLY | Feb 3, 2023 45 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 28, 2023 17 days to disclose | Flat·+0.0% +16.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 17, 2023 28 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |